T-cell-mediated immunity is known to be reduced in patients with liver failure, especially in those with severe alcoholic hepatitis, who exhibit high levels of interleukin-10 and low production of interferon-γ [18, 19]. The gene discussed is IL10; the disease is alcoholic hepatitis.